How to buy Core Laboratories stock

Core Laboratories is an oil & gas equipment & services business based in the US. Core Laboratories shares (CLB) are listed on the NYSE and all prices are listed in US Dollars. Core Laboratories employs 3,600 staff and has a trailing 12-month revenue of around $487.3 million.

Core Laboratories stock price (NYSE: CLB)

Use our graph to track the performance of CLB stocks over time.

Core Laboratories shares at a glance

• Key figures

Information last updated 2023-02-03.

Latest market close	$25.67
52-week range	$13.18 - $35.78
50-day moving average more info button	$21.32
200-day moving average more info button	$20.54
Wall St. target price	$22.17
PE ratio more info button	74.6176
Dividend yield more info button	$0.04 (0.16%)
Earnings per share (TTM) more info button	$0.34

Buy Core Laboratories stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Core Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Core Laboratories price performance over time

Historical closes compared with the close of $25.67 from 2023-02-06

1 week (2023-01-31)	0.27%
1 month (2023-01-06)	22.12%
3 months (2022-11-08)	21.20%
6 months (2022-08-08)	54.73%

1 year (2022-02-08)	0.12%
2 years (2021-02-08)	-29.41%
3 years (2020-02-07)	34.5554
5 years (2018-02-07)	103.7464

Is Core Laboratories stock undervalued or overvalued?

Valuing Core Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Core Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Core Laboratories's P/E ratio

Core Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 75x. In other words, Core Laboratories shares trade at around 75x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Core Laboratories's PEG ratio

Core Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.493. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Core Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Core Laboratories's EBITDA

Core Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $58.2 million.

The EBITDA is a measure of a Core Laboratories's overall financial performance and is widely used to measure a its profitability.

Core Laboratories financials

Revenue TTM	$487.3 million
Operating margin TTM	8.35%
Gross profit TTM	$102.4 million
Return on assets TTM	4.4%
Return on equity TTM	9.15%
Profit margin	3.16%
Book value	$3.85
Market capitalisation more info button	$1.2 billion

TTM: trailing 12 months

Core Laboratories share dividends

Dividend payout ratio: 6.9% of net profits

Recently Core Laboratories has paid out, on average, around 6.9% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.16% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Core Laboratories shareholders could enjoy a 0.16% return on their shares, in the form of dividend payments. In Core Laboratories's case, that would currently equate to about $0.04 per share.

While Core Laboratories's payout ratio might seem low, this can signify that Core Laboratories is investing more in its future growth.

Core Laboratories's most recent dividend payout was on 27 November 2022. The latest dividend was paid out to all shareholders who bought their shares by 3 November 2022 (the "ex-dividend date").

Have Core Laboratories's shares ever split?

Core Laboratories's shares were split on a 2:1 basis on 8 July 2010. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Core Laboratories shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Core Laboratories shares which in turn could have impacted Core Laboratories's share price.

Core Laboratories share price volatility

Over the last 12 months, Core Laboratories's shares have ranged in value from as little as $13.1835 up to $35.7753. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Core Laboratories's is 2.6128. This would suggest that Core Laboratories's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Core Laboratories overview

Core Laboratories N. V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production.

Frequently asked questions

What percentage of Core Laboratories is owned by insiders or institutions?
Currently 0.533% of Core Laboratories shares are held by insiders and 108.674% by institutions. How many people work for Core Laboratories?
Latest data suggests 3,600 work at Core Laboratories. When does the fiscal year end for Core Laboratories?
Core Laboratories's fiscal year ends in December. Where is Core Laboratories based?
Core Laboratories's address is: Van Heuven Goedhartlaan 7 B, Amstelveen, Netherlands, 1181 LE What is Core Laboratories's ISIN number?
Core Laboratories's international securities identification number is: NL0000200384 What is Core Laboratories's CUSIP number?
Core Laboratories's Committee on Uniform Securities Identification Procedures number is: N22717107